Patents by Inventor Ravid Shechter

Ravid Shechter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and device for determining efficiency of lactation
    Patent number: 12150772
    Abstract: The invention generally concerns methods and devices for determining inadequate lactation in female subject.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: November 26, 2024
    Assignee: MYMILK LABORATORIES LTD.
    Inventors: Ravid Shechter Ushpizin, Sharon Haramati
  • METHODS AND DEVICE FOR DETERMINING EFFICIENCY OF LACTATION
    Publication number: 20220087594
    Abstract: The invention generally concerns methods and devices for determining inadequate lactation in female subject.
    Type: Application
    Filed: January 28, 2020
    Publication date: March 24, 2022
    Inventors: Ravid SHECHTER USHPIZIN, Sharon HARAMATI
  • DEVICE AND METHOD FOR HANDLING HUMAN BREAST MILK
    Publication number: 20180036461
    Abstract: A device for collecting human breast milk is provided. The device may include at least one evacuated container capable of connecting to at least one first container that is configured to receive expressed human breast milk. The at least one evacuated container mat be connected to the least one first container by a flow unit permitting communication of human breast milk from the first container to the evacuated container. Further provided are methods of collecting breast milk.
    Type: Application
    Filed: February 26, 2015
    Publication date: February 8, 2018
    Applicant: MYMILK LABORATORIES LTD.
    Inventors: Ravid SHECHTER USHPIZIN, Sharon Rachel HARAMATI
  • Human monocyte sub-population for treatment of central nervous system injury
    Patent number: 9314483
    Abstract: A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3+ cells, CD19+ cells, CD56+ cells and optionally of CD16+ cells, for use in treatment of CNS injury is provided.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: April 19, 2016
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Michal Eisenbach-Schwartz, Ester Yoles, Ravid Shechter, Omer Miller